hydromethylthionine has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baddeley, TC; Bentham, P; Bracoud, L; Ganesan, H; Gauthier, S; Hammel, J; Harrington, CR; Jia, J; Kook, K; Murray, AD; Riedel, G; Rubino, CM; Schelter, BO; Shiells, H; Staff, RT; Storey, JMD; Vuksanovic, V; Wischik, CM | 1 |
| Bartochowski, Z; Grossberg, GT; Hashweh, NN; Khoury, R | 1 |
1 review(s) available for hydromethylthionine and Cognitive Decline
| Article | Year |
|---|---|
An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Humans; Methylene Blue; Protein Aggregates; Randomized Controlled Trials as Topic; tau Proteins; Treatment Outcome | 2020 |
1 trial(s) available for hydromethylthionine and Cognitive Decline
| Article | Year |
|---|---|
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Cognitive Dysfunction; Dose-Response Relationship, Drug; Female; Humans; Male; Methylene Blue | 2019 |